CTI BioPharma Corp.
CTI BioPharma Corp. CTIC Peers
See (CTIC) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CTIC | $9.10 | +0.06% | 1.2B | -16.84 | -$0.54 | N/A |
| VRTX | $436.00 | +0.45% | 112B | -113.54 | -$3.84 | N/A |
| REGN | $588.34 | -1.43% | 62.5B | 14.95 | $39.36 | +0.30% |
| SGEN | $228.74 | -0.07% | 43.2B | -57.19 | -$4.00 | N/A |
| ALNY | $289.96 | +0.33% | 37.8B | -138.74 | -$2.09 | N/A |
| ARGX | $587.61 | +1.06% | 35.9B | 35.85 | $16.39 | N/A |
| BNTX | $98.68 | -0.39% | 23.7B | -27.34 | -$3.61 | N/A |
| BGNE | $184.71 | +0.49% | 20.2B | -22.55 | -$8.19 | N/A |
| SMMT | $25.85 | +0.31% | 19.1B | -76.03 | -$0.34 | N/A |
| DNA-WT | $0.27 | -2.76% | 18.7B | N/A | N/A | N/A |
Stock Comparison
CTIC vs VRTX Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, VRTX has a market cap of 112B. Regarding current trading prices, CTIC is priced at $9.10, while VRTX trades at $436.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas VRTX's P/E ratio is -113.54. In terms of profitability, CTIC's ROE is +13.18%, compared to VRTX's ROE of -0.06%. Regarding short-term risk, CTIC is less volatile compared to VRTX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs REGN Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, REGN has a market cap of 62.5B. Regarding current trading prices, CTIC is priced at $9.10, while REGN trades at $588.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas REGN's P/E ratio is 14.95. In terms of profitability, CTIC's ROE is +13.18%, compared to REGN's ROE of +0.15%. Regarding short-term risk, CTIC is less volatile compared to REGN. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs SGEN Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, SGEN has a market cap of 43.2B. Regarding current trading prices, CTIC is priced at $9.10, while SGEN trades at $228.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas SGEN's P/E ratio is -57.19. In terms of profitability, CTIC's ROE is +13.18%, compared to SGEN's ROE of -0.17%. Regarding short-term risk, CTIC is more volatile compared to SGEN. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.
CTIC vs ALNY Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, ALNY has a market cap of 37.8B. Regarding current trading prices, CTIC is priced at $9.10, while ALNY trades at $289.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas ALNY's P/E ratio is -138.74. In terms of profitability, CTIC's ROE is +13.18%, compared to ALNY's ROE of -5.09%. Regarding short-term risk, CTIC is less volatile compared to ALNY. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs ARGX Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, ARGX has a market cap of 35.9B. Regarding current trading prices, CTIC is priced at $9.10, while ARGX trades at $587.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas ARGX's P/E ratio is 35.85. In terms of profitability, CTIC's ROE is +13.18%, compared to ARGX's ROE of +0.16%. Regarding short-term risk, CTIC is less volatile compared to ARGX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs BNTX Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, BNTX has a market cap of 23.7B. Regarding current trading prices, CTIC is priced at $9.10, while BNTX trades at $98.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas BNTX's P/E ratio is -27.34. In terms of profitability, CTIC's ROE is +13.18%, compared to BNTX's ROE of -0.04%. Regarding short-term risk, CTIC is less volatile compared to BNTX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs BGNE Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, BGNE has a market cap of 20.2B. Regarding current trading prices, CTIC is priced at $9.10, while BGNE trades at $184.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas BGNE's P/E ratio is -22.55. In terms of profitability, CTIC's ROE is +13.18%, compared to BGNE's ROE of -0.12%. Regarding short-term risk, CTIC is less volatile compared to BGNE. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs SMMT Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, SMMT has a market cap of 19.1B. Regarding current trading prices, CTIC is priced at $9.10, while SMMT trades at $25.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas SMMT's P/E ratio is -76.03. In terms of profitability, CTIC's ROE is +13.18%, compared to SMMT's ROE of -0.70%. Regarding short-term risk, CTIC is less volatile compared to SMMT. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs DNA-WT Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, DNA-WT has a market cap of 18.7B. Regarding current trading prices, CTIC is priced at $9.10, while DNA-WT trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas DNA-WT's P/E ratio is N/A. In terms of profitability, CTIC's ROE is +13.18%, compared to DNA-WT's ROE of -0.63%. Regarding short-term risk, CTIC is less volatile compared to DNA-WT. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs RPRX Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, RPRX has a market cap of 18.2B. Regarding current trading prices, CTIC is priced at $9.10, while RPRX trades at $32.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas RPRX's P/E ratio is 13.24. In terms of profitability, CTIC's ROE is +13.18%, compared to RPRX's ROE of +0.16%. Regarding short-term risk, CTIC is less volatile compared to RPRX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs UTHR Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, UTHR has a market cap of 13.9B. Regarding current trading prices, CTIC is priced at $9.10, while UTHR trades at $307.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas UTHR's P/E ratio is 12.26. In terms of profitability, CTIC's ROE is +13.18%, compared to UTHR's ROE of +0.19%. Regarding short-term risk, CTIC is less volatile compared to UTHR. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs GMAB Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, GMAB has a market cap of 12.8B. Regarding current trading prices, CTIC is priced at $9.10, while GMAB trades at $20.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas GMAB's P/E ratio is 12.24. In terms of profitability, CTIC's ROE is +13.18%, compared to GMAB's ROE of +0.26%. Regarding short-term risk, CTIC is less volatile compared to GMAB. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs KRTX Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, KRTX has a market cap of 12.6B. Regarding current trading prices, CTIC is priced at $9.10, while KRTX trades at $329.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas KRTX's P/E ratio is -28.09. In terms of profitability, CTIC's ROE is +13.18%, compared to KRTX's ROE of -0.25%. Regarding short-term risk, CTIC is more volatile compared to KRTX. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.
CTIC vs INCY Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, INCY has a market cap of 12.4B. Regarding current trading prices, CTIC is priced at $9.10, while INCY trades at $64.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas INCY's P/E ratio is 321.23. In terms of profitability, CTIC's ROE is +13.18%, compared to INCY's ROE of +0.01%. Regarding short-term risk, CTIC is less volatile compared to INCY. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs EXEL Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, EXEL has a market cap of 11.6B. Regarding current trading prices, CTIC is priced at $9.10, while EXEL trades at $42.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas EXEL's P/E ratio is 19.36. In terms of profitability, CTIC's ROE is +13.18%, compared to EXEL's ROE of +0.29%. Regarding short-term risk, CTIC is less volatile compared to EXEL. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs BMRN Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, BMRN has a market cap of 11B. Regarding current trading prices, CTIC is priced at $9.10, while BMRN trades at $57.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas BMRN's P/E ratio is 21.31. In terms of profitability, CTIC's ROE is +13.18%, compared to BMRN's ROE of +0.09%. Regarding short-term risk, CTIC is less volatile compared to BMRN. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs MRNA Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, MRNA has a market cap of 10.2B. Regarding current trading prices, CTIC is priced at $9.10, while MRNA trades at $26.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas MRNA's P/E ratio is -3.01. In terms of profitability, CTIC's ROE is +13.18%, compared to MRNA's ROE of -0.30%. Regarding short-term risk, CTIC is less volatile compared to MRNA. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs ASND Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, ASND has a market cap of 9.8B. Regarding current trading prices, CTIC is priced at $9.10, while ASND trades at $162.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas ASND's P/E ratio is -24.62. In terms of profitability, CTIC's ROE is +13.18%, compared to ASND's ROE of +1.91%. Regarding short-term risk, CTIC is less volatile compared to ASND. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs RXDX Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, RXDX has a market cap of 9.6B. Regarding current trading prices, CTIC is priced at $9.10, while RXDX trades at $199.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas RXDX's P/E ratio is -56.47. In terms of profitability, CTIC's ROE is +13.18%, compared to RXDX's ROE of -0.31%. Regarding short-term risk, CTIC is more volatile compared to RXDX. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.
CTIC vs IMGN Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, IMGN has a market cap of 8.7B. Regarding current trading prices, CTIC is priced at $9.10, while IMGN trades at $31.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas IMGN's P/E ratio is -111.55. In terms of profitability, CTIC's ROE is +13.18%, compared to IMGN's ROE of +0.05%. Regarding short-term risk, CTIC is more volatile compared to IMGN. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.
CTIC vs CORT Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, CORT has a market cap of 8.3B. Regarding current trading prices, CTIC is priced at $9.10, while CORT trades at $78.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas CORT's P/E ratio is 68.43. In terms of profitability, CTIC's ROE is +13.18%, compared to CORT's ROE of +0.20%. Regarding short-term risk, CTIC is less volatile compared to CORT. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs CERE Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, CERE has a market cap of 8.2B. Regarding current trading prices, CTIC is priced at $9.10, while CERE trades at $44.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas CERE's P/E ratio is -16.47. In terms of profitability, CTIC's ROE is +13.18%, compared to CERE's ROE of -0.99%. Regarding short-term risk, CTIC is more volatile compared to CERE. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.
CTIC vs ROIVW Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, ROIVW has a market cap of 7.8B. Regarding current trading prices, CTIC is priced at $9.10, while ROIVW trades at $2.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas ROIVW's P/E ratio is -0.67. In terms of profitability, CTIC's ROE is +13.18%, compared to ROIVW's ROE of -0.02%. Regarding short-term risk, CTIC is less volatile compared to ROIVW. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs ROIV Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, ROIV has a market cap of 7.8B. Regarding current trading prices, CTIC is priced at $9.10, while ROIV trades at $10.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas ROIV's P/E ratio is -10.87. In terms of profitability, CTIC's ROE is +13.18%, compared to ROIV's ROE of -0.02%. Regarding short-term risk, CTIC is less volatile compared to ROIV. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs RVMD Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, RVMD has a market cap of 7.4B. Regarding current trading prices, CTIC is priced at $9.10, while RVMD trades at $39.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas RVMD's P/E ratio is -9.92. In terms of profitability, CTIC's ROE is +13.18%, compared to RVMD's ROE of -0.37%. Regarding short-term risk, CTIC is less volatile compared to RVMD. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs TECH Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, TECH has a market cap of 7.3B. Regarding current trading prices, CTIC is priced at $9.10, while TECH trades at $46.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas TECH's P/E ratio is 56.36. In terms of profitability, CTIC's ROE is +13.18%, compared to TECH's ROE of +0.06%. Regarding short-term risk, CTIC is less volatile compared to TECH. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs HALO Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, HALO has a market cap of 6.7B. Regarding current trading prices, CTIC is priced at $9.10, while HALO trades at $54.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas HALO's P/E ratio is 14.51. In terms of profitability, CTIC's ROE is +13.18%, compared to HALO's ROE of +1.22%. Regarding short-term risk, CTIC is less volatile compared to HALO. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs JAZZ Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, JAZZ has a market cap of 6.7B. Regarding current trading prices, CTIC is priced at $9.10, while JAZZ trades at $108.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas JAZZ's P/E ratio is 14.68. In terms of profitability, CTIC's ROE is +13.18%, compared to JAZZ's ROE of +0.12%. Regarding short-term risk, CTIC is less volatile compared to JAZZ. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs RETA Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, RETA has a market cap of 6.6B. Regarding current trading prices, CTIC is priced at $9.10, while RETA trades at $172.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas RETA's P/E ratio is -66.29. In terms of profitability, CTIC's ROE is +13.18%, compared to RETA's ROE of +0.47%. Regarding short-term risk, CTIC is more volatile compared to RETA. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.
CTIC vs BPMC Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, BPMC has a market cap of 6.6B. Regarding current trading prices, CTIC is priced at $9.10, while BPMC trades at $101.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas BPMC's P/E ratio is -40.44. In terms of profitability, CTIC's ROE is +13.18%, compared to BPMC's ROE of -0.49%. Regarding short-term risk, CTIC is less volatile compared to BPMC. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs VRNA Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, VRNA has a market cap of 6.4B. Regarding current trading prices, CTIC is priced at $9.10, while VRNA trades at $75.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas VRNA's P/E ratio is -37.53. In terms of profitability, CTIC's ROE is +13.18%, compared to VRNA's ROE of -0.90%. Regarding short-term risk, CTIC is less volatile compared to VRNA. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs BBIO Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, BBIO has a market cap of 6.3B. Regarding current trading prices, CTIC is priced at $9.10, while BBIO trades at $33.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas BBIO's P/E ratio is -9.37. In terms of profitability, CTIC's ROE is +13.18%, compared to BBIO's ROE of +0.49%. Regarding short-term risk, CTIC is less volatile compared to BBIO. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs MDGL Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, MDGL has a market cap of 5.9B. Regarding current trading prices, CTIC is priced at $9.10, while MDGL trades at $267.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas MDGL's P/E ratio is -14.99. In terms of profitability, CTIC's ROE is +13.18%, compared to MDGL's ROE of -0.51%. Regarding short-term risk, CTIC is less volatile compared to MDGL. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs TLX Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, TLX has a market cap of 5.6B. Regarding current trading prices, CTIC is priced at $9.10, while TLX trades at $16.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas TLX's P/E ratio is 184.44. In terms of profitability, CTIC's ROE is +13.18%, compared to TLX's ROE of +0.14%. Regarding short-term risk, CTIC is less volatile compared to TLX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs ABCM Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, ABCM has a market cap of 5.5B. Regarding current trading prices, CTIC is priced at $9.10, while ABCM trades at $23.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas ABCM's P/E ratio is 2399.00. In terms of profitability, CTIC's ROE is +13.18%, compared to ABCM's ROE of -0.01%. Regarding short-term risk, CTIC is more volatile compared to ABCM. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.
CTIC vs ISEE Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, ISEE has a market cap of 5.5B. Regarding current trading prices, CTIC is priced at $9.10, while ISEE trades at $39.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas ISEE's P/E ratio is -22.44. In terms of profitability, CTIC's ROE is +13.18%, compared to ISEE's ROE of -0.39%. Regarding short-term risk, CTIC is less volatile compared to ISEE. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs TGTX Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, TGTX has a market cap of 5.5B. Regarding current trading prices, CTIC is priced at $9.10, while TGTX trades at $34.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas TGTX's P/E ratio is 138.28. In terms of profitability, CTIC's ROE is +13.18%, compared to TGTX's ROE of +0.19%. Regarding short-term risk, CTIC is less volatile compared to TGTX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs NUVL Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, NUVL has a market cap of 5.3B. Regarding current trading prices, CTIC is priced at $9.10, while NUVL trades at $73.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas NUVL's P/E ratio is -16.63. In terms of profitability, CTIC's ROE is +13.18%, compared to NUVL's ROE of -0.31%. Regarding short-term risk, CTIC is less volatile compared to NUVL. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs IONS Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, IONS has a market cap of 5.2B. Regarding current trading prices, CTIC is priced at $9.10, while IONS trades at $32.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas IONS's P/E ratio is -11.03. In terms of profitability, CTIC's ROE is +13.18%, compared to IONS's ROE of -0.00%. Regarding short-term risk, CTIC is less volatile compared to IONS. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs AXSM Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, AXSM has a market cap of 5.2B. Regarding current trading prices, CTIC is priced at $9.10, while AXSM trades at $105.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas AXSM's P/E ratio is -18.21. In terms of profitability, CTIC's ROE is +13.18%, compared to AXSM's ROE of -3.64%. Regarding short-term risk, CTIC is less volatile compared to AXSM. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs ADMA Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, ADMA has a market cap of 4.9B. Regarding current trading prices, CTIC is priced at $9.10, while ADMA trades at $20.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas ADMA's P/E ratio is 24.31. In terms of profitability, CTIC's ROE is +13.18%, compared to ADMA's ROE of +0.72%. Regarding short-term risk, CTIC is less volatile compared to ADMA. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs ALKS Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, ALKS has a market cap of 4.8B. Regarding current trading prices, CTIC is priced at $9.10, while ALKS trades at $29.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas ALKS's P/E ratio is 13.98. In terms of profitability, CTIC's ROE is +13.18%, compared to ALKS's ROE of +0.25%. Regarding short-term risk, CTIC is less volatile compared to ALKS. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs ALPN Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, ALPN has a market cap of 4.5B. Regarding current trading prices, CTIC is priced at $9.10, while ALPN trades at $64.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas ALPN's P/E ratio is -101.52. In terms of profitability, CTIC's ROE is +13.18%, compared to ALPN's ROE of -0.15%. Regarding short-term risk, CTIC is more volatile compared to ALPN. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.
CTIC vs OPT Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, OPT has a market cap of 4.2B. Regarding current trading prices, CTIC is priced at $9.10, while OPT trades at $3.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas OPT's P/E ratio is -1.52. In terms of profitability, CTIC's ROE is +13.18%, compared to OPT's ROE of +2.60%. Regarding short-term risk, CTIC is more volatile compared to OPT. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.
CTIC vs PCVX Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, PCVX has a market cap of 4.2B. Regarding current trading prices, CTIC is priced at $9.10, while PCVX trades at $32.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas PCVX's P/E ratio is -8.16. In terms of profitability, CTIC's ROE is +13.18%, compared to PCVX's ROE of -0.17%. Regarding short-term risk, CTIC is less volatile compared to PCVX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs MRTX Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, MRTX has a market cap of 4.1B. Regarding current trading prices, CTIC is priced at $9.10, while MRTX trades at $58.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas MRTX's P/E ratio is -4.82. In terms of profitability, CTIC's ROE is +13.18%, compared to MRTX's ROE of -0.40%. Regarding short-term risk, CTIC is less volatile compared to MRTX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs RYTM Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, RYTM has a market cap of 4B. Regarding current trading prices, CTIC is priced at $9.10, while RYTM trades at $62.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas RYTM's P/E ratio is -22.27. In terms of profitability, CTIC's ROE is +13.18%, compared to RYTM's ROE of -1.80%. Regarding short-term risk, CTIC is less volatile compared to RYTM. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs SLNO Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, SLNO has a market cap of 3.9B. Regarding current trading prices, CTIC is priced at $9.10, while SLNO trades at $76.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas SLNO's P/E ratio is -16.22. In terms of profitability, CTIC's ROE is +13.18%, compared to SLNO's ROE of -0.78%. Regarding short-term risk, CTIC is less volatile compared to SLNO. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs MRUS Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, MRUS has a market cap of 3.8B. Regarding current trading prices, CTIC is priced at $9.10, while MRUS trades at $55.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas MRUS's P/E ratio is -13.25. In terms of profitability, CTIC's ROE is +13.18%, compared to MRUS's ROE of -0.41%. Regarding short-term risk, CTIC is less volatile compared to MRUS. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs RYZB Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, RYZB has a market cap of 3.8B. Regarding current trading prices, CTIC is priced at $9.10, while RYZB trades at $62.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas RYZB's P/E ratio is -57.86. In terms of profitability, CTIC's ROE is +13.18%, compared to RYZB's ROE of +0.83%. Regarding short-term risk, CTIC is more volatile compared to RYZB. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.
CTIC vs CBAY Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, CBAY has a market cap of 3.7B. Regarding current trading prices, CTIC is priced at $9.10, while CBAY trades at $32.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas CBAY's P/E ratio is -32.81. In terms of profitability, CTIC's ROE is +13.18%, compared to CBAY's ROE of -0.32%. Regarding short-term risk, CTIC is more volatile compared to CBAY. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.
CTIC vs SRPT Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, SRPT has a market cap of 3.7B. Regarding current trading prices, CTIC is priced at $9.10, while SRPT trades at $37.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas SRPT's P/E ratio is -14.36. In terms of profitability, CTIC's ROE is +13.18%, compared to SRPT's ROE of -0.20%. Regarding short-term risk, CTIC is less volatile compared to SRPT. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs AKRO Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, AKRO has a market cap of 3.7B. Regarding current trading prices, CTIC is priced at $9.10, while AKRO trades at $46.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas AKRO's P/E ratio is -12.36. In terms of profitability, CTIC's ROE is +13.18%, compared to AKRO's ROE of -0.32%. Regarding short-term risk, CTIC is less volatile compared to AKRO. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs RNA Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, RNA has a market cap of 3.7B. Regarding current trading prices, CTIC is priced at $9.10, while RNA trades at $30.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas RNA's P/E ratio is -10.19. In terms of profitability, CTIC's ROE is +13.18%, compared to RNA's ROE of -0.27%. Regarding short-term risk, CTIC is less volatile compared to RNA. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs ACAD Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, ACAD has a market cap of 3.7B. Regarding current trading prices, CTIC is priced at $9.10, while ACAD trades at $21.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas ACAD's P/E ratio is 16.04. In terms of profitability, CTIC's ROE is +13.18%, compared to ACAD's ROE of +0.35%. Regarding short-term risk, CTIC is less volatile compared to ACAD. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs CYTK Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, CYTK has a market cap of 3.6B. Regarding current trading prices, CTIC is priced at $9.10, while CYTK trades at $30.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas CYTK's P/E ratio is -5.77. In terms of profitability, CTIC's ROE is +13.18%, compared to CYTK's ROE of +8.01%. Regarding short-term risk, CTIC is less volatile compared to CYTK. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs PTCT Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, PTCT has a market cap of 3.6B. Regarding current trading prices, CTIC is priced at $9.10, while PTCT trades at $45.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas PTCT's P/E ratio is 7.06. In terms of profitability, CTIC's ROE is +13.18%, compared to PTCT's ROE of -0.72%. Regarding short-term risk, CTIC is less volatile compared to PTCT. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs KRYS Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, KRYS has a market cap of 3.6B. Regarding current trading prices, CTIC is priced at $9.10, while KRYS trades at $125.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas KRYS's P/E ratio is 30.06. In terms of profitability, CTIC's ROE is +13.18%, compared to KRYS's ROE of +0.14%. Regarding short-term risk, CTIC is less volatile compared to KRYS. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs ACLX Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, ACLX has a market cap of 3.5B. Regarding current trading prices, CTIC is priced at $9.10, while ACLX trades at $63.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas ACLX's P/E ratio is -21.38. In terms of profitability, CTIC's ROE is +13.18%, compared to ACLX's ROE of -0.35%. Regarding short-term risk, CTIC is less volatile compared to ACLX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs SWTX Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, SWTX has a market cap of 3.5B. Regarding current trading prices, CTIC is priced at $9.10, while SWTX trades at $46.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas SWTX's P/E ratio is -13.63. In terms of profitability, CTIC's ROE is +13.18%, compared to SWTX's ROE of -0.51%. Regarding short-term risk, CTIC is less volatile compared to SWTX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs RARE Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, RARE has a market cap of 3.4B. Regarding current trading prices, CTIC is priced at $9.10, while RARE trades at $35.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas RARE's P/E ratio is -6.12. In terms of profitability, CTIC's ROE is +13.18%, compared to RARE's ROE of -1.86%. Regarding short-term risk, CTIC is less volatile compared to RARE. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs CRSP Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, CRSP has a market cap of 3.2B. Regarding current trading prices, CTIC is priced at $9.10, while CRSP trades at $36.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas CRSP's P/E ratio is -8.21. In terms of profitability, CTIC's ROE is +13.18%, compared to CRSP's ROE of -0.20%. Regarding short-term risk, CTIC is less volatile compared to CRSP. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs VKTX Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, VKTX has a market cap of 3B. Regarding current trading prices, CTIC is priced at $9.10, while VKTX trades at $26.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas VKTX's P/E ratio is -23.26. In terms of profitability, CTIC's ROE is +13.18%, compared to VKTX's ROE of -0.14%. Regarding short-term risk, CTIC is less volatile compared to VKTX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs CPRX Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, CPRX has a market cap of 3B. Regarding current trading prices, CTIC is priced at $9.10, while CPRX trades at $24.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas CPRX's P/E ratio is 15.60. In terms of profitability, CTIC's ROE is +13.18%, compared to CPRX's ROE of +0.28%. Regarding short-term risk, CTIC is less volatile compared to CPRX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs MTSR Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, MTSR has a market cap of 2.9B. Regarding current trading prices, CTIC is priced at $9.10, while MTSR trades at $27.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas MTSR's P/E ratio is -10.75. In terms of profitability, CTIC's ROE is +13.18%, compared to MTSR's ROE of -0.63%. Regarding short-term risk, CTIC is less volatile compared to MTSR. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs MORF Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, MORF has a market cap of 2.9B. Regarding current trading prices, CTIC is priced at $9.10, while MORF trades at $56.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas MORF's P/E ratio is -14.88. In terms of profitability, CTIC's ROE is +13.18%, compared to MORF's ROE of -0.27%. Regarding short-term risk, CTIC is more volatile compared to MORF. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.
CTIC vs MOR Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, MOR has a market cap of 2.9B. Regarding current trading prices, CTIC is priced at $9.10, while MOR trades at $18.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas MOR's P/E ratio is -12.64. In terms of profitability, CTIC's ROE is +13.18%, compared to MOR's ROE of +7.43%. Regarding short-term risk, CTIC is less volatile compared to MOR. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs SRRK Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, SRRK has a market cap of 2.8B. Regarding current trading prices, CTIC is priced at $9.10, while SRRK trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas SRRK's P/E ratio is -11.76. In terms of profitability, CTIC's ROE is +13.18%, compared to SRRK's ROE of -1.18%. Regarding short-term risk, CTIC is less volatile compared to SRRK. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs PTGX Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, PTGX has a market cap of 2.8B. Regarding current trading prices, CTIC is priced at $9.10, while PTGX trades at $45.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas PTGX's P/E ratio is 58.54. In terms of profitability, CTIC's ROE is +13.18%, compared to PTGX's ROE of +0.09%. Regarding short-term risk, CTIC is less volatile compared to PTGX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs CRNX Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, CRNX has a market cap of 2.8B. Regarding current trading prices, CTIC is priced at $9.10, while CRNX trades at $29.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas CRNX's P/E ratio is -7.83. In terms of profitability, CTIC's ROE is +13.18%, compared to CRNX's ROE of -0.31%. Regarding short-term risk, CTIC is less volatile compared to CRNX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs KDNY Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, KDNY has a market cap of 2.7B. Regarding current trading prices, CTIC is priced at $9.10, while KDNY trades at $40.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas KDNY's P/E ratio is -12.47. In terms of profitability, CTIC's ROE is +13.18%, compared to KDNY's ROE of -0.41%. Regarding short-term risk, CTIC is less volatile compared to KDNY. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs LEGN Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, LEGN has a market cap of 2.7B. Regarding current trading prices, CTIC is priced at $9.10, while LEGN trades at $28.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas LEGN's P/E ratio is -24.50. In terms of profitability, CTIC's ROE is +13.18%, compared to LEGN's ROE of -0.20%. Regarding short-term risk, CTIC is less volatile compared to LEGN. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs MYOV Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, MYOV has a market cap of 2.6B. Regarding current trading prices, CTIC is priced at $9.10, while MYOV trades at $26.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas MYOV's P/E ratio is -14.05. In terms of profitability, CTIC's ROE is +13.18%, compared to MYOV's ROE of +0.50%. Regarding short-term risk, CTIC is more volatile compared to MYOV. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.
CTIC vs MLTX Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, MLTX has a market cap of 2.5B. Regarding current trading prices, CTIC is priced at $9.10, while MLTX trades at $38.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas MLTX's P/E ratio is -16.93. In terms of profitability, CTIC's ROE is +13.18%, compared to MLTX's ROE of -0.00%. Regarding short-term risk, CTIC is less volatile compared to MLTX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs IMVT Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, IMVT has a market cap of 2.5B. Regarding current trading prices, CTIC is priced at $9.10, while IMVT trades at $14.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas IMVT's P/E ratio is -5.52. In terms of profitability, CTIC's ROE is +13.18%, compared to IMVT's ROE of -0.78%. Regarding short-term risk, CTIC is less volatile compared to IMVT. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs PRVB Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, PRVB has a market cap of 2.4B. Regarding current trading prices, CTIC is priced at $9.10, while PRVB trades at $24.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas PRVB's P/E ratio is -16.43. In terms of profitability, CTIC's ROE is +13.18%, compared to PRVB's ROE of +1.33%. Regarding short-term risk, CTIC is more volatile compared to PRVB. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.
CTIC vs APGE Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, APGE has a market cap of 2.4B. Regarding current trading prices, CTIC is priced at $9.10, while APGE trades at $39.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas APGE's P/E ratio is -10.94. In terms of profitability, CTIC's ROE is +13.18%, compared to APGE's ROE of -0.19%. Regarding short-term risk, CTIC is less volatile compared to APGE. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs LBPH Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, LBPH has a market cap of 2.3B. Regarding current trading prices, CTIC is priced at $9.10, while LBPH trades at $59.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas LBPH's P/E ratio is -26.66. In terms of profitability, CTIC's ROE is +13.18%, compared to LBPH's ROE of -0.33%. Regarding short-term risk, CTIC is more volatile compared to LBPH. This indicates potentially higher risk in terms of short-term price fluctuations for CTIC.
CTIC vs AAPG Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, AAPG has a market cap of 2.3B. Regarding current trading prices, CTIC is priced at $9.10, while AAPG trades at $26.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas AAPG's P/E ratio is -35.78. In terms of profitability, CTIC's ROE is +13.18%, compared to AAPG's ROE of -2.50%. Regarding short-term risk, CTIC is less volatile compared to AAPG. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs XENE Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, XENE has a market cap of 2.3B. Regarding current trading prices, CTIC is priced at $9.10, while XENE trades at $29.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas XENE's P/E ratio is -9.24. In terms of profitability, CTIC's ROE is +13.18%, compared to XENE's ROE of -0.32%. Regarding short-term risk, CTIC is less volatile compared to XENE. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs DICE Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, DICE has a market cap of 2.3B. Regarding current trading prices, CTIC is priced at $9.10, while DICE trades at $47.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas DICE's P/E ratio is -21.91. In terms of profitability, CTIC's ROE is +13.18%, compared to DICE's ROE of +0.56%. Regarding short-term risk, CTIC is less volatile compared to DICE. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs IBRX Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, IBRX has a market cap of 2.2B. Regarding current trading prices, CTIC is priced at $9.10, while IBRX trades at $2.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas IBRX's P/E ratio is -4.44. In terms of profitability, CTIC's ROE is +13.18%, compared to IBRX's ROE of +0.65%. Regarding short-term risk, CTIC is less volatile compared to IBRX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs BCRX Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, BCRX has a market cap of 2.2B. Regarding current trading prices, CTIC is priced at $9.10, while BCRX trades at $10.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas BCRX's P/E ratio is -40.73. In terms of profitability, CTIC's ROE is +13.18%, compared to BCRX's ROE of +0.11%. Regarding short-term risk, CTIC is less volatile compared to BCRX. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs APLS Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, APLS has a market cap of 2.2B. Regarding current trading prices, CTIC is priced at $9.10, while APLS trades at $17.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas APLS's P/E ratio is -9.69. In terms of profitability, CTIC's ROE is +13.18%, compared to APLS's ROE of -1.00%. Regarding short-term risk, CTIC is less volatile compared to APLS. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs MIRM Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, MIRM has a market cap of 2.2B. Regarding current trading prices, CTIC is priced at $9.10, while MIRM trades at $44.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas MIRM's P/E ratio is -27.33. In terms of profitability, CTIC's ROE is +13.18%, compared to MIRM's ROE of -0.34%. Regarding short-term risk, CTIC is less volatile compared to MIRM. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs CALT Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, CALT has a market cap of 2.1B. Regarding current trading prices, CTIC is priced at $9.10, while CALT trades at $40.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas CALT's P/E ratio is -22.73. In terms of profitability, CTIC's ROE is +13.18%, compared to CALT's ROE of -2.10%. Regarding short-term risk, CTIC is less volatile compared to CALT. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs VCYT Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, VCYT has a market cap of 2.1B. Regarding current trading prices, CTIC is priced at $9.10, while VCYT trades at $27.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas VCYT's P/E ratio is 64.67. In terms of profitability, CTIC's ROE is +13.18%, compared to VCYT's ROE of +0.03%. Regarding short-term risk, CTIC is less volatile compared to VCYT. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs ARWR Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, ARWR has a market cap of 2.1B. Regarding current trading prices, CTIC is priced at $9.10, while ARWR trades at $15.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas ARWR's P/E ratio is -12.20. In terms of profitability, CTIC's ROE is +13.18%, compared to ARWR's ROE of -0.46%. Regarding short-term risk, CTIC is less volatile compared to ARWR. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs VCEL Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, VCEL has a market cap of 2.1B. Regarding current trading prices, CTIC is priced at $9.10, while VCEL trades at $40.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas VCEL's P/E ratio is 818.40. In terms of profitability, CTIC's ROE is +13.18%, compared to VCEL's ROE of +0.01%. Regarding short-term risk, CTIC is less volatile compared to VCEL. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs BLTE Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, BLTE has a market cap of 2B. Regarding current trading prices, CTIC is priced at $9.10, while BLTE trades at $61.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas BLTE's P/E ratio is -44.85. In terms of profitability, CTIC's ROE is +13.18%, compared to BLTE's ROE of -0.31%. Regarding short-term risk, CTIC is less volatile compared to BLTE. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs NAMS Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, NAMS has a market cap of 2B. Regarding current trading prices, CTIC is priced at $9.10, while NAMS trades at $17.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas NAMS's P/E ratio is -9.57. In terms of profitability, CTIC's ROE is +13.18%, compared to NAMS's ROE of -0.26%. Regarding short-term risk, CTIC is less volatile compared to NAMS. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs NAMSW Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, NAMSW has a market cap of 2B. Regarding current trading prices, CTIC is priced at $9.10, while NAMSW trades at $8.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas NAMSW's P/E ratio is N/A. In terms of profitability, CTIC's ROE is +13.18%, compared to NAMSW's ROE of -0.26%. Regarding short-term risk, CTIC is less volatile compared to NAMSW. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs KNSA Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, KNSA has a market cap of 2B. Regarding current trading prices, CTIC is priced at $9.10, while KNSA trades at $26.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas KNSA's P/E ratio is -112.04. In terms of profitability, CTIC's ROE is +13.18%, compared to KNSA's ROE of -0.04%. Regarding short-term risk, CTIC is less volatile compared to KNSA. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs HRMY Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, HRMY has a market cap of 2B. Regarding current trading prices, CTIC is priced at $9.10, while HRMY trades at $34.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas HRMY's P/E ratio is 13.04. In terms of profitability, CTIC's ROE is +13.18%, compared to HRMY's ROE of +0.24%. Regarding short-term risk, CTIC is less volatile compared to HRMY. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs LGND Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, LGND has a market cap of 2B. Regarding current trading prices, CTIC is priced at $9.10, while LGND trades at $101.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas LGND's P/E ratio is -13.94. In terms of profitability, CTIC's ROE is +13.18%, compared to LGND's ROE of -0.16%. Regarding short-term risk, CTIC is less volatile compared to LGND. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs DNLI Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, DNLI has a market cap of 1.9B. Regarding current trading prices, CTIC is priced at $9.10, while DNLI trades at $13.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas DNLI's P/E ratio is -5.03. In terms of profitability, CTIC's ROE is +13.18%, compared to DNLI's ROE of -0.36%. Regarding short-term risk, CTIC is less volatile compared to DNLI. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs CGON Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, CGON has a market cap of 1.9B. Regarding current trading prices, CTIC is priced at $9.10, while CGON trades at $25.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas CGON's P/E ratio is -16.96. In terms of profitability, CTIC's ROE is +13.18%, compared to CGON's ROE of -0.17%. Regarding short-term risk, CTIC is less volatile compared to CGON. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs KYMR Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, KYMR has a market cap of 1.9B. Regarding current trading prices, CTIC is priced at $9.10, while KYMR trades at $29.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas KYMR's P/E ratio is -9.48. In terms of profitability, CTIC's ROE is +13.18%, compared to KYMR's ROE of -0.30%. Regarding short-term risk, CTIC is less volatile compared to KYMR. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.
CTIC vs FOLD Comparison
CTIC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTIC stands at 1.2B. In comparison, FOLD has a market cap of 1.9B. Regarding current trading prices, CTIC is priced at $9.10, while FOLD trades at $6.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTIC currently has a P/E ratio of -16.84, whereas FOLD's P/E ratio is -69.11. In terms of profitability, CTIC's ROE is +13.18%, compared to FOLD's ROE of -0.17%. Regarding short-term risk, CTIC is less volatile compared to FOLD. This indicates potentially lower risk in terms of short-term price fluctuations for CTIC.